Aptevo Therapeutics(APVO) - 2022 Q4 - Annual Report

th | --- | --- | --- | |-----------------------------------------------------------------------------|------------------|-----------------------------------------------------------------------| | | | | | Securities registered pursuant to Section 12(b) of the Act: | | | | Title of Each Class | Trading Symbol | Name of Exchange on Which Registered | | Common Stock, $0.001 par value per share | APVO | The Nasdaq Stock Market LLC (The Nasdaq Capital Market) | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Was ...